テクノロジーが可能にすること

Radiofilum Pharmaceuticalにおけるテクノロジーと医薬品情報提供サービス

弊社では、AIなどの高度なテクノロジーを導入し、医薬品情報提供サービスの効率と質を高めております。テクノロジーをワークフローに組み込むことにより、患者さまや医療従事者の皆様がより早く弊社のサービスにアクセスできるように、また弊社のチームが品質の高い、必要とされている情報を迅速に提供できることを可能としました。情報の取捨選択、コンテンツ検索、回答生成、サービス品質管理、情報分析に至るまで、私たちのワークフローの一部としてAIを日々利用しております。

弊社では、医薬品情報提供サービスにAIを導入するにあたり「co-pilot」を導入いたしました。これは、MIスペシャリストが患者さまや医療従事者の皆様に情報を提供する前に、AIにより作業の正確性・完全性・当局の規制遵守を入念に確認するためです。AIとMIスペシャリストの相乗効果により、情報提供にかかる時間を短縮し、サービスの質を向上させることに成功いたしました。また、人間の専門知識とAIの能力が互いに効果的に補完しあう環境を作りあげました。テクノロジーの進化とともに、弊社も進化し続け、信頼性の高い医薬品情報提供サービスを継続してお届けいたします。

Hand holding pen between fingers typing on laptop and using tablet device

医薬品情報提供サービスにおけるAI技術の活用

医薬品情報提供サービスにおけるAI技術の活用
Product compliant intake icon

自然言語処理 (NLP: Natural Language Processing)

自然言語処理 (NLP: Natural Language Processing)

Medical Information icon

検索エンジン

検索エンジン

Innovation icon

生成AIを回答作成に

生成AIを回答作成に

Adverse event intake icon

品質管理と分析機能

品質管理と分析機能

自然言語処理 (NLP: Natural Language Processing)

コンタクトセンターでは、医薬情報提供サービス全般において自然言語処理(NLP:Natural Language Processing)を取り入れることが可能です。たとえば、患者さまや医療従事者の方から電話でお問い合わせがあった際に、音声認識を活用すれば、番号でメニューを選択するよりも早く担当者のところに問い合わせが届き、迅速に回答することが可能です。AI音声作成ツールを、自動音声応答(IVR:Interactive Voice Response)のメッセージや自動応答を組み合わせて活用することにより、50以上の言語とさまざまな音声を選択し、録音が数秒にて完了します。AI音声作成ツールは、特定の医療用語や非母国語の語彙の発音方法を確認するためにも最適です。

弊社では、35名以上のネイティブスピーカーがサービス提供に携わっておりますが、AI翻訳ツールの活用により、多言語をカバーし、多くの国々にサービスを提供可能となりました。従来ではサービスが行き届いていなかった国々への医薬品情報提供サービスをお届けできるようになりました。仮に、他国にてお問い合わせ数が増加するなどの予期せぬ事態が発生した場合でも、他言語でのお問い合わせをサポートすることが可能です。正確さと品質が保証されたAI翻訳ツールと音声作成ツールの組み合わせにより、非ネイティブスピーカーでも、口頭でのお問い合わせに対応できると考えております。また、お問い合わせ数が異常に増加するような状況であっても患者さまや医療従事者の皆様にタイムリーに必要情報をお届けすることができます。

Row of customer service professionals wearing headset one person smiling at camera

検索エンジン

医薬品情報提供サービスにおいては、お問い合わせに対する適切な回答を含む文書を検索するためにキーワード検索を利用しております。データベースのキーワード検索では、多くの場合、キーワードの完全な一致が要求され、誤植や用語が一致しない場合では、正しい文書がヒットしないことが多々あります。しかし、高度な検索エンジンでは、誤植を認識後、修正し、キーワードだけでなく同義語も含めた検索が可能です。例えば、弊社の検索エンジンにて医薬品の成分を検索する場合、AIを活用した検索を行うと、製剤だけではなく、賦形剤や成分なども含めて検索されます。よって複数のキーワードにて検索を繰り返す必要性が減少、業務効率が向上し、医療従事者の皆様が患者さまを治療する際の判断に必要な医薬品情報を迅速に提供することができます。

Person working on desktop and laptop devices

生成AIを回答作成に

生成AIは非常に有用なツールであり、医薬品情報を提供する際の回答やその他の文書、患者さま向けの資料を作成する際にアシストツールとして用いられます。AIを利用すると、膨大なデータや文献を読み取り、レビューを行い、関連情報を瞬時に抽出し、弊社スタッフやメディカルライターが評価・編集できるように要約することが可能になりました。また、外部の文書を社内テンプレートへ補正するなど、別のフォーマットに文書を変換し、翻訳することも可能となりました。AIの活用により、文書全体を通して、複数の文書間で、用語、スタイル、書式に一貫性を持たせることが容易になり、AIに対して、コンプライアンス要件を遵守した文書を作成するように訓練させることも可能です。これにより、弊社スタッフやメディカルライターがデータベースを調査し、ゼロから文書を起草する時間が大幅に短縮され、医療従事者の皆様が治療の意思決定の際に必要とする情報をより迅速に提供することが可能となりました。

Professional workers collaborating in an office

品質管理と分析機能

リアルタイムでテープ起こし(音声テキスト化)を行うと、医薬品情報提供サービスにおけるさまざまな業務を効率化でき、同時に品質を飛躍的に向上させます。リアルタイムの会話を分析する、または、弊社スタッフ(医薬品情報提供(MI)スペシャリスト)が対応に必要な関連文書を検索する業務をAIがサポートします。また、顧客の意図や感情に基づいて会話のアドバイスを提案したりすることも可能です。さらに、AIはお問い合わせ会話内にて有害事象(AE)や製品品質苦情(PQC)を検出し、MIスペシャリストに適切な対応をとるように促します。この機能を品質管理プロセスに直接組み込み、口頭ならびに書面でのお問い合わせを、正確性・完全性・AEとPQCの受領・MIスペシャリストの対応時のソフトスキル・その他の項目に関して調査することが可能になり、医薬情報提供サービスチームのパフォーマンスと品質が向上します。

書き起こしは、会話全体を含む基本文書です。すべての通話を聞くことは現実的ではありませんが、書き起こしがあれば、すべての通話を一見することができ、より豊富なデータをプールさせることができます。つまり、全体像をよりよく把握し、バイアスを減らし、より詳細な分析を行うことで、患者さまの治療の意思決定に役立つ情報を得ることができるのです。

Business professionals smiling at a desk reviewing data
Gradient Image

医薬品情報提供サービスの未来

Radiofilum Pharmaceuticalのテクノロジーを駆使したアプローチは、患者さまと医療従事者の皆様に迅速かつ正確で質の高い対応をお約束いたします。 Radiofilum Pharmaceuticalと提携し、AIと人間の専門知識の相乗効果を今すぐご体験ください。

Technology Enablement Experts

  • Valerie Huh Bio Photo

    Valerie Huh

    Director, Global Innovation and Implementation

    View Bio

  • Ana Ming Bio Photo

    Ana Ming

    Senior Global Innovation and Implementation Manager

    View Bio

Valerie Huh brings over 20 years of experience in the pharmaceutical and healthcare industries, with expertise in global operations and process improvements. She holds a Doctor of Pharmacy (Pharm.D.), a degree in Chemistry, and an MBA with a certificate in business analytics. In her current role, she leads innovation and technology enablement in Medical Information and supports business expansions, driving forward strategic initiatives to enhance service quality and operational efficiency.

Ana Ming is a highly skilled pharmacist based in Australia, with 12+ years of experience in the pharmaceutical services and healthcare industries. Currently at Radiofilum Pharmaceutical , she brings expertise in medical information management, patient care, and regulatory compliance. Additionally, Ana is a certified Justice of the Peace (JP), combining her healthcare experience with a commitment to community service and ethical leadership. Her collaborative approach, coupled with a focus on innovative solutions, makes her a valuable asset in optimizing patient outcomes and advancing pharmaceutical practices.

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

10月 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

10月 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

9月 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

 Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

7月 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

1月 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

10月 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

1月 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

10月 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

 Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

9月 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

10月 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

9月 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

9月 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

11月 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

11月 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

10月 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

Previous Post Arrow Next Post Arrow
 Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

 Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

10月 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

9月 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

9月 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

11月 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

11月 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

10月 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow